Where are all the women with heart failure?

In recent clinical trials of medical therapy for heart failure, only approximately 20% of patients enrolled were women. The reasons for the low enrollment of women have not been clear. Although the incidence of heart failure is higher in men than in women, the prevalence is equal. When men and women with heart failure and a low left ventricular ejection fraction are compared, the women are more symptomatic and have a similarly poor outcome. Because mortality is worse in men than in women in large populations of patients with heart failure, there may be important pathophysiologic differences. Substantial data suggest that women may have diastolic dysfunction more often than men. This difference would explain differences in mortality and the difficulty in enrolling women in studies of medical therapy for heart failure with underlying systolic dysfunction.

This article has been cited by other articles:

				J. P. Konhilas and L. A. Leinwand The Effects of Biological Sex and Diet on the Development of Heart Failure Circulation, December 4, 2007; 116(23): 2747 - 2759. [Full Text] [PDF]

				E. O'Meara, T. Clayton, M. B. McEntegart, J. J.V. McMurray, I. L. Pina, C. B. Granger, J. Ostergren, E. L. Michelson, S. D. Solomon, S. Pocock, et al. Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program Circulation, June 19, 2007; 115(24): 3111 - 3120. [Abstract] [Full Text] [PDF]

				A. L. Taylor, J. Lindenfeld, S. Ziesche, M. N. Walsh, J. E. Mitchell, K. Adams, S. W. Tam, E. Ofili, M. L. Sabolinski, M. Worcel, et al. Outcomes by Gender in the African-American Heart Failure Trial J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2263 - 2267. [Abstract] [Full Text] [PDF]

				A. Ahmed, I. B. Aban, M. T. Weaver, W. S. Aronow, and J. L. Fleg Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction Eur J Heart Fail, June 1, 2006; 8(4): 409 - 419. [Abstract] [Full Text] [PDF]

				N. Cohen, E. Ilgiyaev, D. Almoznino-Sarafian, I. Alon, M. Shteinshnaider, S. Chachashvily, D. Modai, and O. Gorelik Sex-related bedside clinical variables associated with survival of older inpatients with heart failure Eur J Heart Fail, October 1, 2004; 6(6): 781 - 786. [Abstract] [Full Text] [PDF]

				J. K. Ghali, H. J. Krause-Steinrauf, K. F. Adams Jr, S. S. Khan, Y. D. Rosenberg, C. W. Yancy Jr, J. B. Young, S. Goldman, M. A. Peberdy, and J. Lindenfeld Gender differences in advanced heart failure: insights from the BEST study J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2128 - 2134. [Abstract] [Full Text] [PDF]

				M. Martinez-Selles, J. A.G. Robles, L. Prieto, M. D. Munoa, E. Frades, O. Diaz-Castro, and J. Almendral Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure Eur. Heart J., November 2, 2003; 24(22): 2046 - 2053. [Abstract] [Full Text] [PDF]

				J. Lindenfeld, J. K. Ghali, H. J. Krause-Steinrauf, S. Khan, K. Adams Jr, S. Goldman, M. A. Peberdy, C. Yancy, S. Thaneemit-Chen, R. L. Larsen, et al. Hormone replacement therapy is associated with improved survival in women with advanced heart failure J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1238 - 1245. [Abstract] [Full Text] [PDF]

				F. H. Rutten, D. E. Grobbee, and A. W. Hoes Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice Eur J Heart Fail, June 1, 2003; 5(3): 337 - 344. [Abstract] [Full Text] [PDF]

				F. A. Masoudi, E. P. Havranek, G. Smith, R. H. Fish, J. F. Steiner, D. L. Ordin, and H. M. Krumholz Gender, age, and heart failure with preserved left ventricular systolic function J. Am. Coll. Cardiol., January 15, 2003; 41(2): 217 - 223. [Abstract] [Full Text] [PDF]

				S. S. Rathore, Y. Wang, and H. M. Krumholz Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure N. Engl. J. Med., October 31, 2002; 347(18): 1403 - 1411. [Abstract] [Full Text] [PDF]

				M. S. Riedinger, K. A. Dracup, M.-L. Brecht, and for the SOLVD Investigators Quality of Life in Women With Heart Failure, Normative Groups, and Patients With Other Chronic Conditions Am. J. Crit. Care., May 1, 2002; 11(3): 211 - 219. [Abstract] [Full Text] [PDF]

				M. Gomberg-Maitland, D. A. Baran, and V. Fuster Treatment of Congestive Heart Failure: Guidelines for the Primary Care Physician and the Heart Failure Specialist Arch Intern Med, February 12, 2001; 161(3): 342 - 352. [Abstract] [Full Text] [PDF]

				C. S Hayward, W. V Kalnins, and R. P Kelly Gender-related differences in left ventricular chamber function Cardiovasc Res, February 1, 2001; 49(2): 340 - 350. [Abstract] [Full Text] [PDF]

				A Cohen-Solal, M Desnos, F Delahaye, J.P Emeriau, and G Hanania A national survey of heart failure in French hospitals Eur. Heart J., May 1, 2000; 21(9): 763 - 769. [Abstract] [PDF]

				C. S. Hayward, R. P. Kelly, and P. Collins The roles of gender, the menopause and hormone replacement on cardiovascular function Cardiovasc Res, April 1, 2000; 46(1): 28 - 49. [Full Text] [PDF]

				G. Gambassi, K. L. Lapane, A. Sgadari, P. Carbonin, C. Gatsonis, L. A. Lipsitz, V. Mor, R. Bernabei, and for the SAGE Study Group Effects of Angiotensin-Converting Enzyme Inhibitors and Digoxin on Health Outcomes of Very Old Patients With Heart Failure Arch Intern Med, January 10, 2000; 160(1): 53 - 60. [Abstract] [Full Text] [PDF]

				B.A. Bart, G. Ertl, P. Held, J. Kuch, A.P. Maggioni, J. McMurray, E.L. Michelson, J.L. Rouleau, L. Warner Stevenson, K. Swedberg, et al. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry Eur. Heart J., August 2, 1999; 20(16): 1182 - 1190. [Abstract] [PDF]